Headlines Expert Newsletters Covid-19 Specialties Trending Feeds Videos

In this interview, Dr Addison Demer discusses the session he moderated, “Mohs for Melanoma Immunohistochemistry Refresher,” at the 2023 ACMS Annual...

  • 1665433257519861760 Profile photo of Madelyn

    In this interview, Dr Addison Demer discusses the session he moderated, “Mohs for Melanoma Immunohistochemistry Refresher,” at the 2023 ACMS Annual Meeting. Watch here: https://t.co/Ommn0jgxCa #derm #dermatology #dermatologist #MohsSurgery #melanoma #IHC - view on twitter

In this interview with The Dermatologist, Dr Abigail Waldman discussed her session, “Managing Melanoma Risk and Prognosis by Gene Expression Profiling and Nodal Staging,”...

  • 1665070868811096067 Profile photo of Madelyn

    In this interview with The Dermatologist, Dr Abigail Waldman discussed her session, "Managing Melanoma Risk and Prognosis by Gene Expression Profiling and Nodal Staging," at the 2023 ACMS Annual Meeting. Read More: https://t.co/h3P2eKOWLo #dermtwitter #dermatologist #melanoma - view on twitter

In this interview, Dr Emily Ruiz discusses her session, “Pro and Con: Contentious Concepts” at the 2023 ACMS Annual Meeting. She covered the topic,...

  • 1664708479171416095 Profile photo of Madelyn

    In this interview, Dr Emily Ruiz discusses her session, “Pro and Con: Contentious Concepts” at the 2023 ACMS Annual Meeting. She covered the topic, “Mohs vs Topical Therapy for Squamous Cell Carcinoma in Situ: Pro Topical Therapy.” https://t.co/B3PITsWKjc #derm #dermatology #SCC - view on twitter

Skip to main content More than 3.7 million patients globally use UCB medicines. In the...

In this episode, interventional cardiologist Dr. Pradeep Nair speaks with Mary Yost, MBA, president of The Sage Group, about her newly published research on...

At the SGO Annual Meeting on Women’s Cancer, Jyoti Mayadev, MD, discusses best practices for treating patients with IB3 cervical cancer, focusing on the...

John C. Messenger, MD, FACC,...

VDM spoke with Dr. Khodorov to discuss the results of the study and what it means for dual therapy regimens for 12-month...

Bradley Knight, MD, shares a timeline of major milestones in the field of EP over the past 25 years, highlighting events that had a...

The ability of this technology to influence the skin microbiome, selectively kill cancer cells, and induce tissue or skin regeneration may give dermatologists a...

  • 1663643958885470210 Profile photo of Madelyn

    The ability of this technology to influence the skin microbiome, selectively kill cancer cells, and induce tissue or skin regeneration: major impact on the treatment of skin disorders. Read more: https://t.co/lliN6BvRlY #dermtwitter #dermatology #TheDermatologist #skincancer - view on twitter